EyePod Bayer

Hosted on Acast. See acast.com/privacy for more information.

Welcome to EyePod Bayer!

In this episode we talk about Sars-Cov-2 effects on the vessels.

Enjoy!

[email protected]

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Welcome to EyePod Bayer and a summary of the Nordic Retina Meeting, arranged by Bayer Scandinavia on the 4th - 5th of Feb 2021.

The first day focused on the treatment regimens, follow-up and how to exit treatment of nAMD, followed the second day about clinical experiences from the Nordic countries and treatment regimens of RVO, and finally a session on Quality of life and resource allocation for patients with visual impairment.

Here, we give you a short summary including some segments from the meeting.

-Treatment regimens in nAMD with prof Jean-Francois Korobelnik
-Imaging in nAMD and RVO with prof Giovanni Staurenghi
-Exit treatment in nAMD patients with prof Justus Garweg and Dr Stamatios Aslanis
-Introduction to RVO with Dr Elin Gunnlaugsdottir
-Health Economy and Quality of Life with prof Hannu Uusitalu

Let us know if you liked this summary by sending us an e-mail.

If you are from Scandinavia, let us know if you want the recordings.

[email protected]

MA-M_AFL-DK-0061-1

Hosted on Acast. See acast.com/privacy for more information.

Welcome back to EyePod Bayer and another episode of this imaging series.

Today we have the honor and pleasure to welcome back Jakob Grauslund, Clinical Professor and Consultant at the Research Unit of Ophthalmology at the University in Odense. Jakob is going to share with us his experiences and expertise as a clinician and researcher in diabetes, and especially how OCT-A can be used as a tool in the management of diabetic retinopathy.

This is the third part where we will continue to talk about OCT-A in Diabetic Retinopathy!

Did you like this episode? Let us know your thoughts!

[email protected]

Hosted on Acast. See acast.com/privacy for more information.

Welcome back to EyePod Bayer and another episode of this imaging series.

Today we have the honor and pleasure to welcome back Jakob Grauslund, Clinical Professor and Consultant at the Research Unit of Ophthalmology at the University in Odense. Jakob is going to share with us his experiences and expertise as a clinician and researcher in diabetes, and especially how OCT-A can be used as a tool in the management of diabetic retinopathy.

Stay tuned for the third part where we will continue to talk about OCT-A in Diabetic Retinopathy!

Did you like this episode? Let us know your thoughts!

[email protected]

Hosted on Acast. See acast.com/privacy for more information.

Welcome to EyePod Bayer!

In this episode, our moderators professor Michael Larsen and Dr Elin Gunnlaugsdottir gives us all their reasons to why you should register to attend the virtual Nordic Retina Meeting 2021, which will be on 4-5th of February 2021, with both Nordic and international speakers. 

This is an reminder, to those of you in the Nordic countries who have already received an invitation, to register.

Link to agenda and registration (agenda at the bottom):

lyyti.fi/reg/Bayer_4546/se

or e-mail to

[email protected]

MA-M_AFL-DK-0025-1

Hosted on Acast. See acast.com/privacy for more information.

Welcome back to EyePod Bayer and another episode of this imaging series.

Today we have the honor and pleasure to welcome back Jakob Grauslund, Clinical Professor and Consultant at the Research Unit of Ophthalmology at the University in Odense. Jakob is going to share with us his experiences and expertise as a clinician and researcher in diabetes, and especially how OCT or OCT-angiography can be used as a tool in the management of diabetic retinopathy.

In this first part, we will focus on OCT. Stay tuned for the second part where we talk about OCT-A in Diabetic Retinopathy!

Did you like this episode? Let us know your thoughts!

[email protected]

MA-M_AFL-DK-0036-1

Hosted on Acast. See acast.com/privacy for more information.

Welcome to a new episode of this imaging series on EyePod Bayer.

In the previous parts of this series, we talked about the anterior segment, and now we are going to continue with imaging of the back of the eye and retina with OCT and OCT-A , beginning with wet AMD.

This is the third part of the interview with Neil and Stamatis, where we talk about OCT-A in clinical practice with focus on wet AMD. 
In the next interviews, we will talk about OCT and OCT-A in Diabetic Retinopathy, stay tuned! 

Enjoy!

[email protected]

Hosted on Acast. See acast.com/privacy for more information.

Welcome to a new episode of this imaging series on EyePod Bayer.

In the previous parts of this series, we talked about the anterior segment, and now we are going to continue with imaging of the back of the eye and retina with OCT and OCT-A , beginning with wet AMD.

This is the second part of the interview with Neil and Stamatis, where we talk about OCT in clinical practice with focus on wet AMD. In the next part, we will talk about OCT-A, stay tuned! 

Enjoy!

[email protected]

Hosted on Acast. See acast.com/privacy for more information.